Shopping Cart
- Remove All
Your shopping cart is currently empty
γ-Fibrinogen 377-395
😃Good
Catalog No. T80683Cas No. 957792-67-5
γ-Fibrinogen377-395 is a peptide derived from fibrinogen, functioning both as an inhibitory molecule and an epitope. It inhibits microglial activation, disrupts fibrin-Mac-1 interactions in vitro, and mitigates experimental autoimmune encephalomyelitis (EAE) in murine models in vivo. This compound is relevant for research into multiple sclerosis (MS) and other neuroinflammatory disorders characterized by blood-brain barrier compromise and microglial activation [1].
γ-Fibrinogen 377-395
😃Good
Catalog No. T80683Cas No. 957792-67-5
γ-Fibrinogen377-395 is a peptide derived from fibrinogen, functioning both as an inhibitory molecule and an epitope. It inhibits microglial activation, disrupts fibrin-Mac-1 interactions in vitro, and mitigates experimental autoimmune encephalomyelitis (EAE) in murine models in vivo. This compound is relevant for research into multiple sclerosis (MS) and other neuroinflammatory disorders characterized by blood-brain barrier compromise and microglial activation [1].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | γ-Fibrinogen377-395 is a peptide derived from fibrinogen, functioning both as an inhibitory molecule and an epitope. It inhibits microglial activation, disrupts fibrin-Mac-1 interactions in vitro, and mitigates experimental autoimmune encephalomyelitis (EAE) in murine models in vivo. This compound is relevant for research into multiple sclerosis (MS) and other neuroinflammatory disorders characterized by blood-brain barrier compromise and microglial activation [1]. |
| In vitro | The compound γ-Fibrinogen377-395 at a concentration of 200 μM inhibits the binding of fibrinogen to Mac-1, thereby reducing the adhesion of Mac-1 overexpressing cells to immobilized fibrinogen. Additionally, γ-Fibrinogen377-395 suppresses the activation of microglia [1]. |
| In vivo | γ-Fibrinogen377-395 (30 μg/mouse; intranasal administration; once daily for 40 days) improved motor function in mice without affecting peripheral immune responses or altering coagulation properties. Additionally, mice immunized with γ377-395 peptide before EAE induction showed enhanced motor strength and coordination compared to the control group [1]. |
| Molecular Weight | 2229.66 |
| Formula | C100H165N25O28S2 |
| Cas No. | 957792-67-5 |
Storage & Solubility Information
| Storage | keep away from moisture | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy γ-Fibrinogen 377-395 | purchase γ-Fibrinogen 377-395 | γ-Fibrinogen 377-395 cost | order γ-Fibrinogen 377-395 | γ-Fibrinogen 377-395 chemical structure | γ-Fibrinogen 377-395 in vivo | γ-Fibrinogen 377-395 in vitro | γ-Fibrinogen 377-395 formula | γ-Fibrinogen 377-395 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.